DVA · 8-K · 20260804PR000105

Operating Expense Trends

DAVITA INC. · 2026-08-04 · Importance 42 · Surprise 14

Patient-care costs rose to $2.392 billion in the second quarter of 2026 from $2.262 billion in the second quarter of 2025, an increase of $130 million. Six-month patient-care costs were $4.734 billion, up $233 million year over year, primarily because of higher compensation, insurance and health-benefit expenses. General and administrative expense increased to $423 million from $413 million year over year and to $331 million from $320 million sequentially. Sequential G&A growth was primarily driven by higher professional fees, while year-to-date growth reflected higher IT and compensation costs partly offset by lower cybersecurity-incident costs.

Key facts

• Three months ended June 30, 2026 total operating expenses were $2,975,083 thousand ($2,975.083 million). source
• General and administrative expenses were $331 million for the three months ended June 30, 2026 (U.S. dialysis segment). source
• Debt expense was $150,256 thousand ($150.256 million) for the three months ended June 30, 2026. source
• Patient care costs per treatment for U.S. dialysis were $277.40 in the three months ended June 30, 2026. source